Top

Published in:

01-04-2014 | Erratum

Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study

Authors: Ralf Gold, Giancarlo Comi, Jacqueline Palace, Arno Siever, Rebecca Gottschalk, Mahendra Bijarnia, Philipp von Rosenstiel, Davorka Tomic, Ludwig Kappos, For the FIRST Study Investigators

Published in: Journal of Neurology | Issue 4/2014

Excerpt

The original version of this article unfortunately contained a mistake. The affiliation of the second author (Giancarlo Comi) is incorrect. The correct affiliation should be: …

Title: Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study
Authors: Ralf Gold
Giancarlo Comi
Jacqueline Palace
Arno Siever
Rebecca Gottschalk
Mahendra Bijarnia
Philipp von Rosenstiel
Davorka Tomic
Ludwig Kappos
For the FIRST Study Investigators
Publication date: 01-04-2014
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 4/2014
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-014-7280-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2014

A follow-up 18F-FDG brain PET study in a case of Hashimoto's encephalopathy causing drug-resistant status epilepticus treated with plasmapheresis

Selective retinal ganglion cell loss in familial dysautonomia

Sensory ataxia as a prominent clinical presentation in three families with mutations in CYP7B1

Unusual features of Creutzfeldt–Jakob disease followed-up in a memory clinic

A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis

Clinical progression of SYNJ1-related early onset atypical parkinsonism: 3-year follow up of the original Italian family